BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 19684521)

  • 1. Increasing incidence of invasive aspergillosis in pediatric hematology oncology patients over the last decade: a retrospective single centre study.
    Rubio PM; Sevilla J; González-Vicent M; Lassaletta A; Cuenca-Estrella M; Díaz MA; Riesco S; Madero L
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):642-6. PubMed ID: 19684521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients.
    Post MJ; Lass-Floerl C; Gastl G; Nachbaur D
    Transpl Infect Dis; 2007 Sep; 9(3):189-95. PubMed ID: 17511828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients.
    Mikulska M; Raiola AM; Bruno B; Furfaro E; Van Lint MT; Bregante S; Ibatici A; Del Bono V; Bacigalupo A; Viscoli C
    Bone Marrow Transplant; 2009 Sep; 44(6):361-70. PubMed ID: 19308042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles.
    De la Serna J; Jarque I; López-Jiménez J; Fernández-Navarro JM; Gómez V; Jurado M; Pascual A; Serrano J; Romero M; Vallejo C
    Rev Esp Quimioter; 2013 Mar; 26(1):64-9. PubMed ID: 23546466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twenty-nine cases of invasive aspergillosis in neutropenic patients.
    Saghrouni F; Ben Youssef Y; Gheith S; Bouabid Z; Ben Abdeljelil J; Khammari I; Fathallah A; Khlif A; Ben Saïd M
    Med Mal Infect; 2011 Dec; 41(12):657-62. PubMed ID: 22036518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
    Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
    Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of aspergillosis in non-neutropenic patients in Swiss teaching hospitals.
    Garbino J; Fluckiger U; Elzi L; Imhof A; Bille J; Zimmerli S
    Clin Microbiol Infect; 2011 Sep; 17(9):1366-71. PubMed ID: 20950331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive aspergillosis in a paediatric haematology department: a 15-year review.
    Crassard N; Hadden H; Piens MA; Pondarré C; Hadden R; Galambrun C; Pracros JP; Souillet G; Basset T; Berthier JC; Philippe N; Bertrand Y
    Mycoses; 2008 Mar; 51(2):109-16. PubMed ID: 18254746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy.
    Hachem RY; Boktour MR; Hanna HA; Husni RN; Torres HA; Afif C; Kontoyiannis DP; Raad II
    Cancer; 2008 Mar; 112(6):1282-7. PubMed ID: 18224662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers.
    Cordonnier C; Ribaud P; Herbrecht R; Milpied N; Valteau-Couanet D; Morgan C; Wade A;
    Clin Infect Dis; 2006 Apr; 42(7):955-63. PubMed ID: 16511759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive aspergillosis in hematopoietic stem cell and solid organ transplantation.
    Salman N; Törün SH; Budan B; Somer A
    Expert Rev Anti Infect Ther; 2011 Mar; 9(3):307-15. PubMed ID: 21417870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
    Nguyen MH; Leather H; Clancy CJ; Cline C; Jantz MA; Kulkarni V; Wheat LJ; Wingard JR
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1043-50. PubMed ID: 21087680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive aspergillosis and allogeneic hematopoietic stem cell transplantation in children: a 15-year experience.
    Crassard N; Hadden H; Pondarré C; Hadden R; Galambrun C; Piens MA; Pracros JP; Souillet G; Basset T; Berthier JC; Philippe N; Bertrand Y
    Transpl Infect Dis; 2008 Jun; 10(3):177-83. PubMed ID: 18331389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive aspergillosis in children with hematological malignancies.
    Ozen M; Dündar NO
    Expert Rev Anti Infect Ther; 2011 Mar; 9(3):299-306. PubMed ID: 21417869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.
    Pagano L; Caira M; Nosari A; Van Lint MT; Candoni A; Offidani M; Aloisi T; Irrera G; Bonini A; Picardi M; Caramatti C; Invernizzi R; Mattei D; Melillo L; de Waure C; Reddiconto G; Fianchi L; Valentini CG; Girmenia C; Leone G; Aversa F
    Clin Infect Dis; 2007 Nov; 45(9):1161-70. PubMed ID: 17918077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting survival in adults with invasive aspergillosis during therapy for hematological malignancies or after hematopoietic stem cell transplantation: Single-center analysis and validation of the Seattle, French, and Strasbourg prognostic indexes.
    Parody R; Martino R; Sánchez F; Subirá M; Hidalgo A; Sierra J
    Am J Hematol; 2009 Sep; 84(9):571-8. PubMed ID: 19676118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aspergillosis in pulmonary transplantation].
    de Pablo A; Ussetti P; Cruz Carreño M; Lázaro T; Ferreiro MJ; López A; Mendaza P; Estada J
    Enferm Infecc Microbiol Clin; 2000 May; 18(5):209-14. PubMed ID: 10974763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk for invasive aspergillosis in patients with lymphoproliferative diseases after autologous hematopoietic SCT.
    Gil L; Kozlowska-Skrzypczak M; Mol A; Poplawski D; Styczynski J; Komarnicki M
    Bone Marrow Transplant; 2009 Jan; 43(2):121-6. PubMed ID: 18794866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters.
    Oren I; Haddad N; Finkelstein R; Rowe JM
    Am J Hematol; 2001 Apr; 66(4):257-62. PubMed ID: 11279636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies.
    Kurosawa M; Yonezumi M; Hashino S; Tanaka J; Nishio M; Kaneda M; Ota S; Koda K; Suzuki N; Yoshida M; Hirayama Y; Takimoto R; Torimoto Y; Mori A; Takahashi T; Iizuka S; Ishida T; Kobayashi R; Oda T; Sakai H; Yamamoto S; Takahashi F; Fukuhara T
    Int J Hematol; 2012 Dec; 96(6):748-57. PubMed ID: 23111539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.